This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Nov;89(11):2556.

doi: 10.2106/JBJS.8911.ebo1.

Celecoxib prevented development of heterotopic ossification better than Ibuprofen after total hip replacement

Michael J Dunbar¹

Affiliations

PMID: 17974907
DOI: 10.2106/JBJS.8911.ebo1

Comment

Celecoxib prevented development of heterotopic ossification better than Ibuprofen after total hip replacement

Michael J Dunbar. J Bone Joint Surg Am. 2007 Nov.

. 2007 Nov;89(11):2556.

doi: 10.2106/JBJS.8911.ebo1.

Author

Michael J Dunbar¹

Affiliation

¹ Dalhousie University Halifax, Nova Scotia.

PMID: 17974907
DOI: 10.2106/JBJS.8911.ebo1

No abstract available

PubMed Disclaimer

Comment on

Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M, Saudan P, Perneger T, Riand N, Keller A, Hoffmeyer P. Saudan M, et al. J Bone Joint Surg Br. 2007 Feb;89(2):155-9. doi: 10.1302/0301-620X.89B2.17747. J Bone Joint Surg Br. 2007. PMID: 17322426 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer